When you add a medication that already causes nausea for 30 to 50 percent of users, the combination can be extremely unpleasant
This made it very difficult for me to lose my regain
Campbell-Thompson, T
You need a repeatable structure that supports your medication, health, and long-term goals
Oral use has occasionally been linked to nausea, and theoretical hypotension concerns exist due to nitric oxide pathway activity
The analysis included 10,997 adults with CM initiating a GLP-1 RA (liraglutide, semaglutide, dulaglutide, exenatide, lixisenatide, or albiglutide) within 12 months of diagnosis, as well as matched adults initiating topiramate.The researchers found that compared with topiramate, GLP-1 RA initiators had a lower risk for emergency department visits (risk ratio [RR], 0.90), hospitalizations (RR, 0.86), nerve blocks (RR, 0.87), and triptan use (RR, 0.87)